Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review (Preprint)
Preprint
- 20 September 2019
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Research using genomic data opens up new insights into health and disease. Being able to use the data in association with health and administrative record data held in safe havens can multiply the benefits. However, there is much discussion about the use of genomic data with perceptions of particular challenges in doing so safely and effectively. OBJECTIVE This study aimed to work toward a risk-utility data governance framework for research using genomic and phenotypic data in an anonymized form for research in safe havens. METHODS We carried out a multifaceted review drawing upon data governance arrangements in published research, case studies of organizations working with genomic and phenotypic data, public views and expectations, and example studies using genomic and phenotypic data in combination. The findings were contextualized against a backdrop of legislative and regulatory requirements and used to create recommendations. RESULTS We proposed recommendations toward a risk-utility model with a flexible suite of controls to safeguard privacy and retain data utility for research. These were presented as overarching principles aligned to the core elements in the data sharing framework produced by the Global Alliance for Genomics and Health and as practical control measures distilled from published literature and case studies of operational safe havens to be applied as required at a project-specific level. CONCLUSIONS The recommendations presented can be used to contribute toward a proportionate data governance framework to promote the safe, socially acceptable use of genomic and phenotypic data in safe havens. They do not purport to eradicate risk but propose case-by-case assessment with transparency and accountability. If the risks are adequately understood and mitigated, there should be no reason that linked genomic and phenotypic data should not be used in an anonymized form for research in safe havens.Keywords
All Related Versions
- Published version: Journal of Medical Internet Research, 22 (5), e16346.
This publication has 26 references indexed in Scilit:
- Public Views on Models for Accessing Genomic and Health Data for Research: Mixed Methods StudyJournal of Medical Internet Research, 2019
- Systematizing Genome Privacy Research: A Privacy-Enhancing Technologies PerspectiveProceedings on Privacy Enhancing Technologies, 2018
- Personalised Medicine, Individual Choice and the Common Good2018
- The Evolution of Public Health Genomics: Exploring Its Past, Present, and FutureFrontiers in Public Health, 2018
- GDPR ENFORCEMENT2017
- Comparative Approaches to Genetic Discrimination: Chasing Shadows?Trends in Genetics, 2017
- Data Safe Havens and Trust: Toward a Common Understanding of Trusted Research Platforms for Governing Secure and Ethical Health ResearchJMIR Medical Informatics, 2016
- Privacy in the Genomic EraACM Computing Surveys, 2015
- GINA, Genetic Discrimination, and Genomic MedicineNew England Journal of Medicine, 2015
- What — If Anything — Is Special about “Genetic Privacy”?2013